Cyclic and innovative: Merck's anti-aging ingredient receives
1st prize in the category of innovative raw material
Innovation was rewarded. Our biomimetic peptide for anti-wrinkle and anti-aging cosmetic products, RonaCare® Cyclopeptide-5 was awarded 1st prize in the category "innovative raw material” during the BSB Innovation Prize ceremonies that took place during this year's In-Cosmetic in Barcelona.
RonaCare® Cyclopeptide-5 is the world’s first homodetic cyclic peptide for cosmetic applications. It is designed to fight wrinkles and improves skin elasticity.
Merck’s RonaCare® Cyclopeptide-5 smoothes wrinkles through its innovative molecular design. Cosmetics manufacturers now have access to a powerful ingredient with proven efficacy that promotes the skin cells’ anti-aging process.
This first place award confirms that the skin care benefits, unique ingredient story and desirable galenic form (liposomal encapsulation) of Cyclopetide-5 represent a true break-through which can be easily formulated into innovative (if not award winning) skin care products.
RonaCare® Cyclopeptide-5 is the first homodetic cyclic peptide for cosmetic applications. Due to its smart design, RonaCare® Cyclopeptide-5 is highly selectivity for its biological target – integrins at the RGD binding site. Tailor-made to fit specific skin cell surface receptors, it mimics natural communication and repair processes of skin. The innovative cyclic molecular design paves the way to anti-aging efficacy in a new dimension.